Pharmaron Beijing Transfers 5.40 Million Treasury H Shares to Trustee for 2025 Award Scheme, Expanding Issued Float by 1.53%

Bulletin Express07-22

Pharmaron Beijing Co., Ltd. disclosed a transfer of 5.40 million treasury H shares on 22 July 2026. The shares were moved to the company’s trustee to facilitate the vesting of awards under the 2025 H Share Award and Trust Scheme.

• Capital structure impact – Issued H shares (excluding treasury) rose 1.53% to 358.11 million from 352.71 million. – Treasury share balance fell to 1.87 million from 7.26 million. – Total issued shares remained unchanged at 359.98 million, indicating no new shares were created; existing treasury shares were re-designated for employee incentives.

• Pricing – The transfer was executed at HKD0 per share as it involved an internal reallocation rather than an on-market sale.

The company secretary confirmed the transaction was authorised by the board and complies with Hong Kong Listing Rules and all relevant regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150820715?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-22 16:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150820715","market":"hk","top_or_hot":-1,"title":"Pharmaron Beijing Transfers 5.40 Million Treasury H Shares to Trustee for 2025 Award Scheme, Expanding Issued Float by 1.53%","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. disclosed a transfer of 5.40 million treasury H shares on 22 July 2026. The shares were moved to the company’s trustee to facilitate the vesting of awards under the 2025 H Share Award and Trust Scheme.</p>\n<p>• Capital structure impact  \n– Issued H shares (excluding treasury) rose 1.53% to 358.11 million from 352.71 million.  \n– Treasury share balance fell to 1.87 million from 7.26 million.  \n– Total issued shares remained unchanged at 359.98 million, indicating no new shares were created; existing treasury shares were re-designated for employee incentives.</p>\n<p>• Pricing  \n– The transfer was executed at HKD0 per share as it involved an internal reallocation rather than an on-market sale.</p>\n<p>The company secretary confirmed the transaction was authorised by the board and complies with Hong Kong Listing Rules and all relevant regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing Transfers 5.40 Million Treasury H Shares to Trustee for 2025 Award Scheme, Expanding Issued Float by 1.53%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing Transfers 5.40 Million Treasury H Shares to Trustee for 2025 Award Scheme, Expanding Issued Float by 1.53%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-22 16:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. disclosed a transfer of 5.40 million treasury H shares on 22 July 2026. The shares were moved to the company’s trustee to facilitate the vesting of awards under the 2025 H Share Award and Trust Scheme.</p>\n<p>• Capital structure impact  \n– Issued H shares (excluding treasury) rose 1.53% to 358.11 million from 352.71 million.  \n– Treasury share balance fell to 1.87 million from 7.26 million.  \n– Total issued shares remained unchanged at 359.98 million, indicating no new shares were created; existing treasury shares were re-designated for employee incentives.</p>\n<p>• Pricing  \n– The transfer was executed at HKD0 per share as it involved an internal reallocation rather than an on-market sale.</p>\n<p>The company secretary confirmed the transaction was authorised by the board and complies with Hong Kong Listing Rules and all relevant regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1150820715","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150820715","pubTimestamp":1784709679,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. disclosed a transfer of 5.40 million treasury H shares on 22 July 2026. The shares were moved to the company’s trustee to facilitate the vesting of awards under the 2025 H...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成北京2025年奖励计划向受托人转让540万股库存H股，已发行流通量增加1.53%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. disclosed a transfer of 5.40 million treasury H shares on 22 July 2026. The shares were moved to the company’s trustee to facilitate the vesting of awards under the 2025 H Share Award and Trust Scheme.\n• Capital structure impact  \n– Issued H shares (excluding treasury) rose 1.53% to 358.11 million from 352.71 million.  \n– Treasury share balance fell to 1.87 million from 7.26 million.  \n– Total issued shares remained unchanged at 359.98 million, indicating no new shares were created; existing treasury shares were re-designated for employee incentives.\n• Pricing  \n– The transfer was executed at HKD0 per share as it involved an internal reallocation rather than an on-market sale.\nThe company secretary confirmed the transaction was authorised by the board and complies with Hong Kong Listing Rules and all relevant regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150820715","isCrawlerRequest":true}